Integrative Gene Tx(PGI*)

N/A

Report date: 2024/05/30 17:46:55

Base Information

Drug NameIntegrative Gene Tx(PGI*)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsHemochromatosisAtherosclerosisCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTome Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesTome Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHemochromatosisAtherosclerosis
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A